RG
GNCA

Redmile Group’s Genocea Biosciences, Inc. GNCA Stock Holding History

Redmile Group’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,456
Closed -$628K – 71
2015
Q3 		$628K Sell
11,456
-66,484
-85% -$6.59M 0.05% 50
2015
Q2 		$8.56M Sell
77,940
-21,673
-22% -$2.01M 0.7% 39
2015
Q1 		$9.45M Buy
+99,613
New +$7.03M 0.85% 40
2014
Q2 		– Sell
-15,656
Closed -$2.28M – 64
2014
Q1 		$2.28M Buy
+15,656
New +$1.92M 0.27% 47

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Redmile Group's GNCA Position: Q4 2015 in Review

Redmile Group sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2015, closing a stake of 11,456 shares — an estimated $628K sold.

Redmile Group first reported a position in GNCA in Q1 2014 and held it in 4 quarters. The position peaked at $9.45M in Q1 2015. 57 funds tracked by Wall St. Rank hold GNCA as of Q4 2015.

  • Redmile Group reported no remaining Genocea Biosciences, Inc. position as of Q4 2015 after selling out during the quarter.
  • Redmile Group sold 11,456 Genocea Biosciences, Inc. shares in Q4 2015, an estimated $628K.
  • Redmile Group first reported a position in Genocea Biosciences, Inc. in Q1 2014 and held it in 4 quarters.
  • Redmile Group's Genocea Biosciences, Inc. position peaked at $9.45M in Q1 2015.
  • 57 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2015.

Based on Redmile Group's 13F filing for Q4 2015, filed 16 Feb 2016.